Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Interview with FDA: Adopting New Strategies to Oversee Global Economy

June 1, 2012

In a special anniversary interview, Washington Editor Jill Wechsler speaks with with FDA Deputy Commissioner Deborah Autor about where the agency is headed.

Developing Alternatives to ELISA-Based Biomarker Assays

June 1, 2012

The authors discuss a new, rapid immunoassay for the detection of biomarkers.

Determining Process Quality Metrics for CMOs

June 1, 2012

Implementing quality by design makes the determination of quality metrics across CMOs and sponsors essential.

25 Years of BioPharma Industry Growth

June 1, 2012

A review of key industry shifts and promises for the future.

How to Respond to Consent Decrees

May 1, 2012

How to handle and respond to a consent decree.

FDA Explores Options to Expand Access to NonPrescription Drugs

May 1, 2012

Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.

A 25-Year Retrospective on the Biotech Business

May 1, 2012

This month, we rewind to an article titled "The Biotechnology Industry: A First Quarter Snapshot."

Changing Your Business Model

May 1, 2012

BioPharm talks with Tarja Mottram, CEO of Action for Results, on design-for-value concepts, management, and cross-functionality.

Channeling Steve Jobs

May 1, 2012

Service providers must focus on delivering a superior customer experience.

ADVERTISEMENT

ADVERTISEMENT

Click here